IFNG and type 2 diabetes mellitus: The exhibition of the M1 phenotype by several factors (e.g., interferon-gamma, tumor necrosis factor α (TNFα), lipopolysaccharide) leads to anti-bacterial, anti-virus, and anti-tumoral activity and the induction of type II diabetes, atherosclerosis, and autoimmune disease.